Baltimore, Maryland Clinical Trials

A listing of Baltimore, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

The primary goal for this study is to evaluate up to 3 dose levels of mRNA-1273 vaccine given to healthy children in 2 doses, 28 days apart.

The Pediatric Centre of Frederick
 (45.6 away) Contact site
  • 90 views
  • 22 Sep, 2021
  • +77 other locations
A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

The main purpose of this study is to measure the amount of lopinavir/ritonavir (two anti-HIV medications) in the blood. Results from this study will be compared to the levels of the drugs that have been found in other studies that showed that these medications were safe and effective.

lopinavir/ritonavir
kaletra
ritonavir
HIV Vaccine
lopinavir
Johns Hopkins University NICHD CRS (5092)
 (1.7 away) Contact site
  • 340 views
  • 08 Nov, 2020
  • +56 other locations
Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy

The primary objectives of this study are to examine the clinical efficacy of nusinersen administered intrathecally at higher doses to participants with SMA, as measured by change in Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) total score (Part B); to examine the safety and tolerability of …

nusinersen
muscle atrophy
gene deletion
The Johns Hopkins Hospital
 (1.7 away) Contact site
  • 42 views
  • 22 Sep, 2021
  • +54 other locations
Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

Many types of cancer are primarily treated with surgery and patient survival is directly related to the extent to which the tumor is able to be removed. It is often difficult for surgeons to distinguish tumor tissue from normal tissue or to detect tumor cells that have spread from the …

Johns Hopkins University
 (1.7 away) Contact site
  • 0 views
  • 22 Sep, 2021
  • +9 other locations
Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

The proposed study is a Type 1 hybrid effectiveness-implementation trial. Individuals with opioid use disorder in county jails throughout the state of Maryland will be randomly assigned within gender within jail to one of two groups: Arm 1. XR-B (n=120). XR-B in jail followed by 6 monthly injections post-release at …

  • 0 views
  • 29 Aug, 2021
  • 1 location
Study to Evaluate the Safety Tolerability and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children <12 Years of Age

This is a Phase 1/2/3 study in healthy children <12 years of age. Dependent upon safety and/or immunogenicity data generated during the course of this study, and the resulting assessment of benefit-risk, the safety, tolerability, and immunogenicity of BNT162b2 in participants <6 months of age may subsequently be evaluated.

Center for Immunization Research Inpatient Unit
 (3.8 away) Contact site
  • 90 views
  • 22 Aug, 2021
  • +114 other locations
The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

This study is a Phase 2/3 prospective, double-blind, randomized, multi-center, placebo-controlled study for prevention of acute GVHD (aGVHD) in subjects undergoing an allogeneic hematopoietic cell transplant (HCT).

alpha-1-antitrypsin
myeloablative conditioning
myeloproliferative disorder
acute graft-versus-host disease
transplant conditioning
Johns Hopkins Hospital
 (1.7 away) Contact site
  • 25 views
  • 20 Aug, 2021
  • +27 other locations
GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

The purpose of this study is to assess the efficacy and safety of itacitinib in combination with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host disease (cGVHD).

cell transplantation
platelet count
corticosteroids
prednisone
neutrophil count
University of Maryland - Greenebaum Cancer Center
 (0.2 away) Contact site
  • 0 views
  • 11 Aug, 2021
  • +160 other locations
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

This study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I) and versus an active comparator (Stage 2) in participants with moderately to severely active CD and will include assessments of clinical response as demonstrated by improvement of symptoms and colonic mucosal appearance as observed on …

budesonide
conventional treatment
humira
prednisone
aminosalicylate
Research Site
 (9.1 away) Contact site
  • 401 views
  • 20 Sep, 2021
  • +320 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
Johns Hopkins University School of Medicine /ID# 211793
 (1.7 away) Contact site
  • 630 views
  • 23 Sep, 2021
  • +926 other locations